$0.32
Galmed Pharmaceuticals is a biotechnology business based in the US. Galmed Pharmaceuticals shares (GLMD) are listed on the NASDAQ and all prices are listed in US Dollars. Galmed Pharmaceuticals employs 3 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Galmed Pharmaceuticals stock
How to buy Galmed Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – GLMD. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Galmed Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Galmed Pharmaceuticals stock price (NASDAQ: GLMD)
Use our graph to track the performance of GLMD stocks over time.Galmed Pharmaceuticals shares at a glance
Latest market close | $0.33 |
---|---|
52-week range | $0.26 - $1.26 |
50-day moving average | $0.34 |
200-day moving average | $0.37 |
Wall St. target price | $1.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.65 |
Is it a good time to buy Galmed Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Galmed Pharmaceuticals price performance over time
Historical closes compared with the close of $0.3346 from 2024-07-22
1 week (2024-07-17) | 4.89% |
---|---|
1 month (2024-06-24) | 7.76% |
3 months (2024-04-24) | -16.35% |
6 months (2024-01-24) | -9.57% |
1 year (2023-07-24) | -72.35% |
---|---|
2 years (2022-07-22) | -42.01% |
3 years (2021-07-23) | 2.61 |
5 years (2019-07-24) | 6.22 |
Galmed Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -29.39% |
Return on equity TTM | -51.38% |
Profit margin | 0% |
Book value | $2.12 |
Market Capitalization | $1.9 million |
TTM: trailing 12 months
Galmed Pharmaceuticals share dividends
We're not expecting Galmed Pharmaceuticals to pay a dividend over the next 12 months.
Have Galmed Pharmaceuticals's shares ever split?
Galmed Pharmaceuticals's shares were split on a 1:15 basis on 14 May 2023. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Galmed Pharmaceuticals shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Galmed Pharmaceuticals shares which in turn could have impacted Galmed Pharmaceuticals's share price.
Galmed Pharmaceuticals share price volatility
Over the last 12 months, Galmed Pharmaceuticals's shares have ranged in value from as little as $0.26 up to $1.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Galmed Pharmaceuticals's is 0.69. This would suggest that Galmed Pharmaceuticals's shares are less volatile than average (for this exchange).
Galmed Pharmaceuticals overview
Galmed Pharmaceuticals Ltd. , a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma.
Frequently asked questions
nullWhat percentage of Galmed Pharmaceuticals is owned by insiders or institutions?
Currently 3.656% of Galmed Pharmaceuticals shares are held by insiders and 3.043% by institutions. How many people work for Galmed Pharmaceuticals?
Latest data suggests 3 work at Galmed Pharmaceuticals. When does the fiscal year end for Galmed Pharmaceuticals?
Galmed Pharmaceuticals's fiscal year ends in December. Where is Galmed Pharmaceuticals based?
Galmed Pharmaceuticals's address is: 16 Tiomkin Street, Tel Aviv, Israel, 6578317 What is Galmed Pharmaceuticals's ISIN number?
Galmed Pharmaceuticals's international securities identification number is: IL0011313900 What is Galmed Pharmaceuticals's CUSIP number?
Galmed Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: M47238106
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Frec review 2024: Low-cost direct indexing and individual stock trading
A deep dive into the highlights and limitations of Frec.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question